BRPI0416030A - pirido-7-pirimidin-7-onas substituìdas com hidroxialquila - Google Patents

pirido-7-pirimidin-7-onas substituìdas com hidroxialquila

Info

Publication number
BRPI0416030A
BRPI0416030A BRPI0416030-4A BRPI0416030A BRPI0416030A BR PI0416030 A BRPI0416030 A BR PI0416030A BR PI0416030 A BRPI0416030 A BR PI0416030A BR PI0416030 A BRPI0416030 A BR PI0416030A
Authority
BR
Brazil
Prior art keywords
pyrimidin
ones
hydroxyalkyl substituted
substituted pyrido
hydroxyalkyl
Prior art date
Application number
BRPI0416030-4A
Other languages
English (en)
Inventor
David Michael Goldstein
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0416030A publication Critical patent/BRPI0416030A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

"PIRIDO-7-PIRIMIDIN-7-ONAS SUBSTITUìDAS COM HIDROXIALQUILA". A presente invenção refere-se a um composto de fórmula I onde X¬ 1¬, Ar¬ 1¬, R¬ 1¬ e R¬ 2¬ são como aqui definidos, e composições compreendendo os mesmos. A presente invenção também fornece métodos para usar os compostos de fórmula I no tratamento de distúrbios mediados por p38 em um paciente.
BRPI0416030-4A 2003-11-13 2004-11-04 pirido-7-pirimidin-7-onas substituìdas com hidroxialquila BRPI0416030A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51978903P 2003-11-13 2003-11-13
PCT/EP2004/012475 WO2005047284A1 (en) 2003-11-13 2004-11-04 Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones

Publications (1)

Publication Number Publication Date
BRPI0416030A true BRPI0416030A (pt) 2007-01-02

Family

ID=34590444

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0416030-4A BRPI0416030A (pt) 2003-11-13 2004-11-04 pirido-7-pirimidin-7-onas substituìdas com hidroxialquila

Country Status (26)

Country Link
US (2) US7348331B2 (pt)
EP (1) EP1685131B1 (pt)
JP (1) JP4616839B2 (pt)
KR (1) KR100816321B1 (pt)
CN (1) CN100455582C (pt)
AR (1) AR046705A1 (pt)
AT (1) ATE356124T1 (pt)
AU (1) AU2004289428B2 (pt)
BR (1) BRPI0416030A (pt)
CA (1) CA2544247A1 (pt)
CO (1) CO5690600A2 (pt)
DE (1) DE602004005238T2 (pt)
DK (1) DK1685131T3 (pt)
ES (1) ES2281843T3 (pt)
HR (1) HRP20070132T3 (pt)
IL (1) IL175284A0 (pt)
MY (1) MY141011A (pt)
NO (1) NO20062256L (pt)
NZ (1) NZ546634A (pt)
PL (1) PL1685131T3 (pt)
PT (1) PT1685131E (pt)
RU (1) RU2348632C2 (pt)
SI (1) SI1685131T1 (pt)
TW (1) TWI349670B (pt)
WO (1) WO2005047284A1 (pt)
ZA (1) ZA200603829B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2656507C (en) * 2006-07-17 2012-03-20 Amgen Inc. Quinazoline and pyridopyrimidine derivatives as p38 kinase inhibitors
CN101568518A (zh) * 2006-12-22 2009-10-28 霍夫曼-拉罗奇有限公司 用于氨基亚烷基二醇合成的化合物和方法
CA2690327A1 (en) * 2007-06-15 2008-12-18 Thomas P. Cleary A novel process for the preparation of 3-amino-pentan-1,5-diol
KR101754664B1 (ko) * 2009-12-18 2017-07-06 템플 유니버시티-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 치환된 피리도〔2,3-ｄ〕피리미딘-7(8ｈ)-온스 및 이의 치료 용도
DK3102577T3 (en) 2014-02-07 2018-11-12 Principia Biopharma Inc QUINOLONDERIVATIVES AS FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITORS
EP3334735B1 (en) 2015-08-11 2025-08-13 Principia Biopharma Inc. Processes for preparing an fgfr inhibitor
CN105418609B (zh) * 2015-12-31 2017-06-23 山东大学 4‑(1,2,3‑三氮唑取代苯胺基)‑吡啶骈嘧啶酮衍生物及其制备方法与应用
US20190060286A1 (en) 2016-02-29 2019-02-28 University Of Florida Research Foundation, Incorpo Chemotherapeutic Methods
RS62040B1 (sr) 2016-06-02 2021-07-30 Abbvie Inc Agonist receptora glukokortikoida i njegovi imunokonjugati
CN115105601A (zh) 2016-06-08 2022-09-27 投资支持有限公司 用于治疗癌症的药物组合
PE20190421A1 (es) 2016-08-17 2019-03-19 Support Venture Gmbh Metodo para prevenir o tratar la perdida de la audicion
KR20190137854A (ko) 2017-04-04 2019-12-11 스트리킨 아게 안과 질병의 예방 또는 치료 방법
ES2927715T3 (es) 2017-10-05 2022-11-10 Fulcrum Therapeutics Inc Inhibidores de la quinasa p38 reducen la expresión de dux4 y de los genes que le siguen para el tratamiento de la FSHD
EP3658192B1 (en) 2017-12-01 2021-04-28 AbbVie Inc. Glucocorticoid receptor agonist and immunoconjugates thereof
KR102831835B1 (ko) 2018-05-21 2025-07-10 네르비아노 메디칼 사이언시스 에스.알.엘. 헤테로축합된 피리돈 화합물 및 idh 억제제로서의 이의 용도
US20210267983A1 (en) 2018-07-13 2021-09-02 Kinarus Ag Combinations of ppar agonists and p38 kinase inhibitors for preventing or treating fibrotic diseases
WO2021089395A1 (en) 2019-11-08 2021-05-14 Nerviano Medical Sciences S.R.L. Gem-disubstituted heterocyclic compounds and their use as idh inhibitors
WO2022034031A1 (en) 2020-08-11 2022-02-17 Kinarus Ag Methods of preventing or treating covid-19 and related viral diseases or disorders

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215216A (en) * 1979-04-18 1980-07-29 American Home Products Corporation 7,8-Dihydro-2,5,8-trisubstituted-7-oxo-pyrido[2,3-d]pyrimidine-6-carboxylic acid derivatives
US5037826A (en) * 1986-10-15 1991-08-06 Schering Corporation 1-substituted naphthyridine and pyridopyrazine derivatives
EP0278686A1 (en) 1987-02-07 1988-08-17 The Wellcome Foundation Limited Pyridopyrimidines methods for their preparation and pharmaceutical formulations thereof
US5149699A (en) * 1991-10-24 1992-09-22 American Home Products Corporation Substituted pyridopyrimidines useful as antgiotensin II antagonists
WO1993017682A1 (en) 1992-03-04 1993-09-16 Abbott Laboratories Angiotensin ii receptor antagonists
IL115256A0 (en) * 1994-11-14 1995-12-31 Warner Lambert Co 6-Aryl pyrido (2,3-d) pyrimidines and naphthyridines and their use
FI971953A7 (fi) 1994-11-14 1997-05-12 Warner Lambert Co Proteiinityrosiinikinaasin välittämää soluproliferaatiota inhiboivat 6 -aryyli-pyrido(2,3-d)pyrimidiinit ja naftyridiinit
US5620981A (en) * 1995-05-03 1997-04-15 Warner-Lambert Company Pyrido [2,3-D]pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation
IL117923A (en) 1995-05-03 2000-06-01 Warner Lambert Co Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds
ES2301194T3 (es) 1997-02-05 2008-06-16 Warner-Lambert Company Llc Pirido 2,3-d pirimidinas y 4-aminopirimidinas como inhibidores de la proliferacion celular.
US5945422A (en) * 1997-02-05 1999-08-31 Warner-Lambert Company N-oxides of amino containing pyrido 2,3-D! pyrimidines
DE69939168D1 (de) 1998-05-26 2008-09-04 Warner Lambert Co Bicyclische pyrimidine und bicyclische 3,4-dihydropyrimidine als inhibitoren der zellvermehrung
US7053070B2 (en) * 2000-01-25 2006-05-30 Warner-Lambert Company Pyrido[2,3-d]pyrimidine-2,7-diamine kinase inhibitors
SK10772002A3 (sk) 2000-01-27 2004-01-08 Warner-Lambert Company Pyridopyrimidinónové deriváty na liečbu neurodegeneratívnych ochorení
AP2002002643A0 (en) 2000-03-06 2002-12-31 Warner Lambert Co 5-alkylpyrido[2,3-d]pyrimidines tyrosine kinase inhibitors
KR100571339B1 (ko) * 2000-08-31 2006-04-17 에프. 호프만-라 로슈 아게 세포증식 억제제로서의 7-옥소 피리도피리미딘
US6518276B2 (en) * 2000-08-31 2003-02-11 Syntex (U.S.A.) Llc 7-oxo-pyridopyrimidines (II)
SK11322003A3 (en) * 2001-02-12 2004-10-05 Hoffmann La Roche 6-Substituted pyrido-pyrimidines
NZ534069A (en) * 2002-01-22 2007-03-30 Warner Lambert Co 2-(Pyridin-2-ylamino)-pyrido[2,3-d]pyrimidin-7-ones to be used to treat neurodegenerative disorders, viruses and cancer
FR2897336B1 (fr) 2006-02-10 2010-07-30 Ranger France Support d'aile pour vehicule automobile

Also Published As

Publication number Publication date
AU2004289428A1 (en) 2005-05-26
KR20060086417A (ko) 2006-07-31
CN1882585A (zh) 2006-12-20
PT1685131E (pt) 2007-05-31
TWI349670B (en) 2011-10-01
US20080119497A1 (en) 2008-05-22
US7750016B2 (en) 2010-07-06
NZ546634A (en) 2010-01-29
AU2004289428B2 (en) 2010-06-03
CA2544247A1 (en) 2005-05-26
CN100455582C (zh) 2009-01-28
US7348331B2 (en) 2008-03-25
CO5690600A2 (es) 2006-10-31
WO2005047284A1 (en) 2005-05-26
KR100816321B1 (ko) 2008-03-24
HK1099021A1 (zh) 2007-08-03
EP1685131B1 (en) 2007-03-07
SI1685131T1 (sl) 2007-06-30
JP2007510686A (ja) 2007-04-26
DE602004005238T2 (de) 2007-11-08
PL1685131T3 (pl) 2007-08-31
MY141011A (en) 2010-02-25
RU2348632C2 (ru) 2009-03-10
TW200526657A (en) 2005-08-16
ZA200603829B (en) 2007-10-31
IL175284A0 (en) 2006-09-05
DE602004005238D1 (de) 2007-04-19
EP1685131A1 (en) 2006-08-02
ATE356124T1 (de) 2007-03-15
AR046705A1 (es) 2005-12-21
ES2281843T3 (es) 2007-10-01
DK1685131T3 (da) 2007-07-09
JP4616839B2 (ja) 2011-01-19
HRP20070132T3 (en) 2007-05-31
NO20062256L (no) 2006-06-06
US20050107408A1 (en) 2005-05-19
RU2006120486A (ru) 2008-01-20

Similar Documents

Publication Publication Date Title
BR0316350A (pt) Diaminotriazóis úteis como inibidores de proteìna cinases
EA200800172A1 (ru) 2,4-диаминопиримидины как ингибиторы aurora
EA200600294A1 (ru) [1,8] нафтиридин-2-оны и родственные соединения для лечения шизофрении
MX2009006195A (es) Compuestos basados en 4-fenil-6-(2,2,2-trifluoro-1-feniletoxi)piri midina y metodos de su uso.
HRP20110566T8 (en) Azaindoles useful as inhibitors of jak and other protein kinases
BR0307351A (pt) Composto, composição farmacêutica, método para tratar uma condição ou estado de doença mediados pela atividade de p38 quinase ou mediados por citocinas produzidas pela atividade de p38 quinase, uso de um composto, e, processo para preparar um composto
TW200609227A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
EA200802213A1 (ru) Способы лечения заболеваний крови
NZ539841A (en) Hydroxyethylamine derivatives for the treatment of alzheimer's disease
TW200510333A (en) Benzimidazole compounds
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
BRPI0418251B8 (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo
DE602004014117D1 (de) Thiazole zur verwendung als inhibitoren von protein-kinasen
UY27872A1 (es) Inhibidores de caspasa y usos de los mismos.
CY1111733T1 (el) Παραγωγα 2-(1η-ινδολυλοσουλφανυλ)-βενζυλαμινης ως ssri
CY1109906T1 (el) Παραγωγα c3-kyano εποθιλονης
TW200634012A (en) 3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents
SE0401970D0 (sv) Novel compounds
ATE389395T1 (de) Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson
MY135850A (en) Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
BR0316723A (pt) Derivados de anilinopirazol úteis para o tratamento de diabetes
NO20062256L (no) Hydroksyalkylsubstituerte pyrido-7-pyrimidin-7-oner
BG108180A (en) Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases
PL1725536T3 (pl) Pochodne imidazoliny mające czynność CB1-antagonistyczną
BRPI0407913A (pt) antagonistas receptores de ccr-3

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2260 DE 29/04/2014.